These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30641835)

  • 1. Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma.
    Chen CH; Chen PY; Lin YY; Feng LY; Chen SH; Chen CY; Huang YC; Huang CY; Jung SM; Chen LY; Wei KC
    J Neurosurg; 2020 Jan; 132(1):168-179. PubMed ID: 30641835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).
    Yang CH; Yue J; Pfeffer SR; Fan M; Paulus E; Hosni-Ahmed A; Sims M; Qayyum S; Davidoff AM; Handorf CR; Pfeffer LM
    J Biol Chem; 2014 Sep; 289(36):25079-87. PubMed ID: 25059666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SiRNA-mediated knockdown against NUF2 suppresses tumor growth and induces cell apoptosis in human glioma cells.
    Huang SK; Qian JX; Yuan BQ; Lin YY; Ye ZX; Huang SS
    Cell Mol Biol (Noisy-le-grand); 2014 Nov; 60(4):30-6. PubMed ID: 25481014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
    Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
    Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo.
    Han L; Zhang AL; Xu P; Yue X; Yang Y; Wang GX; Jia ZF; Pu PY; Kang CS
    Med Oncol; 2010 Sep; 27(3):843-52. PubMed ID: 19728186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    Fukunaga T; Fujita Y; Kishima H; Yamashita T
    PLoS One; 2018; 13(11):e0206552. PubMed ID: 30388142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.
    Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C
    Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
    Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
    Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and Quantitative Analysis of IDH1 Mutation in Progressive Gliomas by Allele-Specific qPCR and Western Blot Analysis.
    Perrech M; Dreher L; Röhn G; Stavrinou P; Krischek B; Toliat M; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828396. PubMed ID: 30943868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway.
    Kouchi M; Shibayama Y; Ogawa D; Miyake K; Nishiyama A; Tamiya T
    J Neurosurg; 2017 Oct; 127(4):819-828. PubMed ID: 28059652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    Fukui N; Yawata T; Nakajo T; Kawanishi Y; Higashi Y; Yamashita T; Aratake T; Honke K; Ueba T
    J Neurosurg; 2021 Jun; 134(6):1772-1782. PubMed ID: 32707539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
    Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
    BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
    Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
    Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
    Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
    J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.